Specifically, IGF2BP1 maintains the stability of MYC by binding to the coding region determinant of m6A-modified MYC in a hypoxic microenvironment, thereby promoting the self-renewal of breast cancer stem cells 28. The gene discussed is IGF2BP1; the disease is breast carcinoma.